Severe inflammatory tinea capitis in a child receiving baricitinib therapy for alopecia areata
- PMID: 36964103
- DOI: 10.1016/j.annder.2023.02.001
Severe inflammatory tinea capitis in a child receiving baricitinib therapy for alopecia areata
Conflict of interest statement
Declaration of Competing Interest EM has paid activities as a consultant, advisor, or speaker for AbbVie, LEO Pharma, Lilly, and Sanofi. None of the other authors have any conflicts of interest to disclose.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources